Difference between revisions of "Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5 (Q9645)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Kaushal C, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Fifth Author string (P153): Sharma S, #quickstatements; #temporary_batch_1590155508986) |
||
| Property / Fifth Author string | |||
| + | Sharma S | ||
| Property / Fifth Author string: Sharma S / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Tyagi S
0 references
Gupta P
0 references
Saini AS
0 references
2011
0 references
J. Adv. Pharm. Technol. Res.
0 references
2
0 references
The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases (English)
0 references
236-240
0 references
Kaushal C
0 references
Sharma S
0 references
